(Reuters) - Swiss drugmaker Roche Holding AG said on Thursday it would buy the rest of U.S. cancer data company Flatiron Health for $1.9 billion to speed development of cancer medicines and support its efforts to price them based on how well they work.
from Reuters: Health News http://ift.tt/2EHazV4 February 15, 2018 at 02:34PM
No comments:
Post a Comment